Schmidt P J Investment Management Inc Moleculin Biotech, Inc. Call Options Transaction History

Schmidt P J Investment Management Inc

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $83.2M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Schmidt P J Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Schmidt P J Investment Management Inc with notifications on news.